EGFR and cancer: Using digital droplet PCR (ddPCR) and duplex sequencing (Duplex-seq), we sought for evidence of EGFR-driver mutations in non-cancerous lung tissue from patients with lung cancer or with cancers of other organs and from individuals with no evidence of cancer (Extended Data Figs. 7 and 8a and Supplementary Table 7).